Ask Aeroz

Type the question you actually came here with.

Drug Supply Chain Security Act · checked 24 October 2026

DSCSA is in force. One exemption is left: 27 November 2027.

The Drug Supply Chain Security Act (DSCSA), passed in 2013 as Title II of the Drug Quality and Security Act, requires manufacturers, repackagers, wholesale distributors and dispensers of US prescription drugs to trace each package electronically, trade only with authorized partners, and verify, quarantine and report suspect product. Its enhanced requirements apply from 27 November 2023.

  • DSCSA · THE DATES
  • 27 Nov 2013law signed
  • 27 Nov 2023enhanced rules apply
  • 27 Nov 2024stabilization ends
  • 27 Nov 2027small dispensers
  • FDA, 6 Aug 2026last exemption
Checked 24 October 2026

Where it stands.

Each line names the source it was checked against.

Enhanced requirements
Interoperable, electronic, package-level tracing under section 582(g) of the FD&C Act applies from 27 November 2023. FDA's one-year stabilization period ended on 27 November 2024. FD&C Act §582(g); FDA
Exemptions that ended
FDA's exemptions for eligible trading partners ended on 27 May 2025 for manufacturers and repackagers, on 27 August 2025 for wholesale distributors, and on 27 November 2025 for dispensers with 26 or more full-time pharmacists and pharmacy technicians. FDA, exemptions of October 2024
Small dispensers
On 6 August 2026 FDA extended the small-dispenser exemption to 27 November 2027. It covers dispensers whose owning company has 25 or fewer full-time employees licensed as pharmacists or qualified as pharmacy technicians, counted as of 27 November 2026. FDA, 6 August 2026
Requests for records
A wholesale distributor answers an FDA request for transaction information within 1 business day, not to exceed 48 hours; a dispenser within 2 business days. 21 U.S.C. §360eee-1(c)(1)(C), (d)(1)(D)
Records
Transaction information and transaction statements are kept for at least 6 years. 21 U.S.C. §360eee-1
The rule

What every trading partner has to do.

  • Trade with authorized partners

    Buy and sell only with licensed or registered trading partners, and check a new partner's licence or registration before the first order.

  • Pass the transaction data

    Transaction information and a transaction statement travel with every change of ownership, electronically and at package level.

  • Read the product identifier

    Each package carries the NDC, a serial number, the lot and the expiry date, in a 2D data carrier and in human-readable form.

  • Handle suspect product

    Quarantine and investigate suspect product, verify its product identifier, and notify FDA on Form 3911 and your trading partners within 24 hours of finding it illegitimate.

Where Aeroz fits

What Aeroz does, on its own.

  • A unit, not only a serial

    The GS1 DataMatrix shows a serial number exists. A chip on the pack is designed to show that the package in hand is the one that serial was issued to, which is what a suspect-product investigation needs.

  • One custody record

    Every handoff becomes a signed, timestamped GS1 EPCIS event against the unit, alongside the transaction data your serialization system already exchanges.

  • Answers on the clock

    FDA's 1- and 2-business-day request windows are met from the event log, not rebuilt from invoices.

Questions

DSCSA, answered.

When does the DSCSA small dispenser exemption end?

The DSCSA small-dispenser exemption ends on 27 November 2027; FDA extended it on 6 August 2026. It applies to dispensers whose owning company has 25 or fewer full-time employees licensed as pharmacists or qualified as pharmacy technicians, counted as of 27 November 2026. Larger dispensers have been under the enhanced requirements since 27 November 2025.

What does DSCSA require of a pharmacy?

Under DSCSA a pharmacy, as a dispenser, must buy only from authorized trading partners, accept product only with its transaction information and statement, keep those records for six years, quarantine and investigate suspect product, and answer an FDA request for records within 2 business days. Small dispensers are exempt from the enhanced electronic requirements until 27 November 2027.

What is the DSCSA product identifier?

The DSCSA product identifier is the National Drug Code, a unique serial number, the lot number and the expiration date, printed on each package in human-readable form and in a machine-readable 2D data carrier, which in practice is a GS1 DataMatrix. Manufacturers have had to apply it since November 2017.

Does DSCSA require EPCIS?

DSCSA requires interoperable, electronic exchange of transaction information but does not name a data format. In practice US trading partners exchange GS1 EPCIS files, most often EPCIS 1.2 XML following the GS1 US implementation guideline; EPCIS 2.0 adds JSON and a REST interface.

Does DSCSA require a chip or RFID?

No. DSCSA requires the 2D product identifier and electronic data exchange. It does not require a chip. A chip lets a pharmacist or an investigator confirm that the package in hand is the one the serial number was issued to, which a printed code alone cannot show.

Sources: FDA: Drug Supply Chain Security Act · FDA: exemptions under DSCSA · ArentFox Schiff on the 6 August 2026 extension · 21 U.S.C. §360eee-1. Checked 24 October 2026. Not legal advice.

Key facts · DSCSA

The Drug Supply Chain Security Act's enhanced requirements apply from 27 November 2023. The last FDA exemption, for small dispensers, ends on 27 November 2027.

Law
2013 · FD&C Act §581–582
In force
27 Nov 2023
Last exemption
27 Nov 2027
Records
6 years